# Comment on Dashtipour et al. Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information. Toxins 2024, 16, 442

**Authors:** Richard Trosch, Daniel Parreirinha, Susanne Proeschel

PMC · DOI: 10.3390/toxins17040190 · 2025-04-11

## Full-text entities

- **Diseases:** Cervical Dystonia (MESH:D014103), Muscle Weakness (MESH:D018908), Dysphagia (MESH:D003680)

---
Source: https://tomesphere.com/paper/PMC12031422